文献速递关节外科创伤骨科

全髋关节置换术后脱位闭合复位后深静脉血栓和肺栓塞发生率惊人地高

Alarmingly High Rates of Deep Vein Thrombosis and Pulmonary Embolism Following Closed Reduction for Dislocated Total Hip Arthroplasty.
PubMed 文献 · J Arthroplasty · 2024-11-17

该研究利用住院患者数据库分析初次全髋关节置换术后90天内脱位并接受闭合复位的患者,发现其深静脉血栓和肺栓塞风险显著高于未脱位患者,校正后深静脉血栓aOR 2.5、肺栓塞aOR 2.2,作者建议对脱位患者考虑药物预防。

要点

  • 初次全髋关节置换术后90天内脱位并闭合复位者肺栓塞发生率0.9% vs 未脱位者0.3%(P < 0.001)。
  • 该组深静脉血栓发生率1.6% vs 未脱位者0.5%(P < 0.001)。
  • 校正混杂后深静脉血栓aOR 2.5(95%CI 1.8-3.4)、肺栓塞aOR 2.2(95%CI 1.4-3.3)。

核心结论

  • 初次全髋关节置换术后脱位接受闭合复位的患者深静脉血栓和肺栓塞风险惊人地高。
  • 作者认为这些发现应促使外科医生对发生脱位的患者考虑药物预防,即使接受了闭合复位。

研究设计与样本

  • 研究基于住院患者入院数据库识别所有初次全髋关节置换患者。
  • 将术后90天内脱位并接受闭合复位的患者与术后90天内未脱位患者进行比较。
  • 比较两组患者人口学特征、合并症、医院特征、术后药物预防药物及术后90天感染率。
  • 采用单变量和多变量回归评估闭合复位治疗的脱位对90天深静脉血栓和肺栓塞风险的影响。

主要发现

  • 共识别550,208例初次全髋关节置换,其中3,700例(0.7%)在90天内发生脱位,2,487例(67.2%)接受闭合复位。
  • 脱位并闭合复位组肺栓塞发生率为0.9%,未脱位组为0.3%(P < 0.001)。
  • 脱位并闭合复位组深静脉血栓发生率为1.6%,未脱位组为0.5%(P < 0.001)。
  • 校正混杂因素后,闭合复位组深静脉血栓风险升高(aOR 2.5,95%CI 1.8至3.4,P < 0.001)。
  • 校正混杂因素后,闭合复位组肺栓塞风险升高(aOR 2.2,95%CI 1.4至3.3,P < 0.001)。

临床怎么用

  • 作者认为这些发现应促使外科医生对发生脱位的患者考虑药物预防,即使接受了闭合复位。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous thromboembolism (VTE) and dislocation are well-described complications following total hip arthroplasty (THA). However, the relationship between THA dislocation and venous thromboembolism remains unclear. This study sought to determine the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) in patients who experience a hip dislocation and subsequent closed reduction following primary THA. METHODS: All primary THA patients were identified in an inpatient admissions database. The THA patients who had a dislocation within 90 days of surgery who were treated with closed reduction were compared to patients who did not dislocate within 90 days of surgery. Differences in patient demographics, comorbidities, hospital characteristics, postoperative chemoprophylactic agents, and 90-day postoperative infectious rates were calculated between the cohorts. Univariate and multivariable regression were used to assess the impact of THA dislocation treated with closed reduction on 90-day DVT and PE risk. RESULTS: There were 550,208 primary THAs identified. Of these patients, 3,700 (0.7%) experienced a dislocation within 90 days, of which 2,487 (67.2%) were treated with closed reduction. Patients who dislocated and underwent closed reduction had increased rates of PE (0.9 versus 0.3%, P < 0.001) and DVT (1.6 versus 0.5%, P < 0.001) compared to patients who did not dislocate. After controlling for confounding factors, patients in the closed reduction group had elevated risks of both DVT (adjusted odds ratio [aOR] 2.5, 95% confidence interval [CI]: 1.8 to 3.4, P < 0.001) and PE (aOR 2.2, 95% CI: 1.4 to 3.3, P < 0.001). DISCUSSION: Patients who undergo closed reduction for dislocation following primary THA have an alarmingly high risk of DVT and PE. These findings should prompt surgeons to consider chemoprophylaxis among patients who experience a dislocation, even when treated with a closed reduction.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Telang SS, Abe E, Miltenberg B, et al. Alarmingly High Rates of Deep Vein Thrombosis and Pulmonary Embolism Following Closed Reduction for Dislocated Total Hip Arthroplasty. J Arthroplasty. 2024. PMID: 39551412. doi:10.1016/j.arth.2024.11.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。